TY - JOUR AU - Kumar, Dhiraj AU - Yadav, Dharmendra Kumar AU - Hassan, Md Imtaiyaz PY - 2021 M3 - Opinion TI - Topical Insights Into the Post-Approval Controversies of Aducanumab JO - Frontiers in Pharmacology UR - https://www.frontiersin.org/articles/10.3389/fphar.2021.787303 VL - 12 SN - 1663-9812 ER -